LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain (Q28539803)
Jump to navigation
Jump to search
scientific article (publication date: 2014)
Language | Label | Description | Also known as |
---|---|---|---|
English | LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain |
scientific article (publication date: 2014) |
Statements
LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain (English)
Cleverton K F Lima
Rafael M Silva
Renata B Lacerda
Bruna L R Santos
Rafaela V Silva
Luciana S Amaral
Eliezer J Barreiro
Marília Z P Guimaraes
18 June 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references